Differential Expression of miR-145 in Children with Kawasaki Disease

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Shimizu, Chisato ^a   Kim, Jihoon ^b   Stepanowsky, Petra ^b   Trinh, Christine ^a   Lau, Hubert D ^a   Akers, Johnny C ^a   Chen, Clark ^a   Kanegaye, John T ^a,c   Tremoulet, Adriana ^a,c   Ohno Machado, Lucila ^b   Burns, Jane C ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 143; MICRORNA 145; MICRORNA 199B; MICRORNA 223; MICRORNA 618; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; CELL DIFFERENTIATION; CELL VACUOLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE CONTROL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE TARGETING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEUTROPHIL; PATHOGENESIS; PROSPECTIVE STUDY; RNA ANALYSIS; RNA ISOLATION; RNA SEQUENCE; RNA TRANSPORT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VALIDATION PROCESS; VASCULAR BIOLOGY; VASCULAR SMOOTH MUSCLE;

ARTERIES; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; GENE EXPRESSION REGULATION; HUMANS; INFANT; MICRORNAS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUCOCUTANEOUS LYMPH NODE SYNDROME; REAL-TIME POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84874627337     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058159     Document Type: Article

References (56)

1. Suzuki A, Kamiya T, Kuwahara N, Ono Y, Kohata T, et al. (1986) Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases. Pediatr Cardiol 7: 3-9.
2. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H, (1974) A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 54: 271-276.
3. Rowley AH, (2011) Kawasaki disease: novel insights into etiology and genetic susceptibility. Annu Rev Med 62: 69-77.
4. Khor CC, Davila S, Breunis WB, Lee YC, Shimizu C, et al. (2011) Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet 43: 1241-1246.
5. Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, et al. (2008) ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 40: 35-42.
6. Onouchi Y, Ozaki K, Burns JC, Shimizu C, Terai M, et al. (2012) A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet 44: 517-521.
7. Shimizu C, Jain S, Davila S, Hibberd ML, Lin KO, et al. (2011) Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ Cardiovasc Genet 4: 16-25.
8. Orenstein JM, Shulman ST, Fox LM, Baker SC, Takahashi M, et al. (2012) Three linked vasculopathic processes characterize kawasaki disease: a light and transmission electron microscopic study. PloS one 7: e38998.
9. Shimizu C, Oharaseki T, Takahashi K, Kottek A, Franco A, et al. (2012) The role of TGF-beta and myofibroblasts in the arteritis of Kawasaki disease. Hum Pathol.
10. Choi WY, Giraldez AJ, Schier AF, (2007) Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430. Science 318: 271-274.
11. Lu LF, Liston A, (2009) MicroRNA in the immune system, microRNA as an immune system. Immunology 127: 291-298.
12. Small EM, Olson EN, (2011) Pervasive roles of microRNAs in cardiovascular biology. Nature 469: 336-342.
13. Hergenreider E, Heydt S, Treguer K, Boettger T, Horrevoets AJ, et al. (2012) Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nature cell biology 14: 249-256.
14. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, et al. (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110: 2747-2771.
15. Langmead B, Trapnell C, Pop M, Salzberg SL, (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25.
16. Langmead B, Salzberg SL, (2012) Fast gapped-read alignment with Bowtie 2. Nat Methods 9: 357-359.
17. Kin T, Yamada K, Terai G, Okida H, Yoshinari Y, et al. (2007) fRNAdb: a platform for mining/annotating functional RNA candidates from non-coding RNA sequences. Nucleic Acids Res 35: D145-148.
18. Friedlander MR, Mackowiak SD, Li N, Chen W, Rajewsky N, (2012) miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res 40: 37-52.
19. Anders S, Huber W, (2010) Differential expression analysis for sequence count data. Genome Biol 11: R106.
20. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B 57: 289-300.
21. Reczko M, Maragkakis M, Alexiou P, Grosse I, Hatzigeorgiou AG, (2012) Functional microRNA targets in protein coding sequences. Bioinformatics 28: 771-776.
22. Vlachos IS, Kostoulas N, Vergoulis T, Georgakilas G, Reczko M, et al. (2012) DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res 40: W498-504.
23. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, et al. (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129: 1401-1414.
24. Tremoulet AH, Jain S, Chandrasekar D, Sun X, Sato Y, et al. (2011) Evolution of laboratory values in patients with Kawasaki disease. Pediatr Infect Dis J 30: 1022-1026.
25. Allantaz F, Cheng DT, Bergauer T, Ravindran P, Rossier MF, et al. (2012) Expression profiling of human immune cell subsets identifies miRNA-mRNA regulatory relationships correlated with cell type specific expression. PLoS One 7: e29979.
26. Gatsiou A, Boeckel JN, Randriamboavonjy V, Stellos K, (2012) MicroRNAs in Platelet Biogenesis and Function: Implications in Vascular Homeostasis and Inflammation. Curr Vasc Pharmacol 10: 524-531.
27. Rangrez AY, Massy ZA, Metzinger-Le Meuth V, Metzinger L, (2011) miR-143 and miR-145: molecular keys to switch the phenotype of vascular smooth muscle cells. Circulation Cardiovascular genetics 4: 197-205.
28. Hergenreider E, Heydt S, Tréguer K, Boettger T, Horrevoets AJ, et al. (2012) Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 14: 249-256.
29. Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, et al. (2010) Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 12: 19-30; sup 11-13.
30. Batliner J, Buehrer E, Fey MF, Tschan MP, (2012) Inhibition of the miR-143/145 cluster attenuated neutrophil differentiation of APL cells. Leuk Res 36: 237-240.
31. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, et al. (2009) miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460: 705-710.
32. Xu N, Papagiannakopoulos T, Pan G, Thomson JA, Kosik KS, (2009) MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 137: 647-658.
33. Boettger T, Beetz N, Kostin S, Schneider J, Kruger M, et al. (2009) Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. The Journal of clinical investigation 119: 2634-2647.
34. Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, et al. (2009) MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 105: 158-166.
35. Xin M, Small EM, Sutherland LB, Qi X, McAnally J, et al. (2009) MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes & development 23: 2166-2178.
36. Takahashi K, Oharaseki T, Naoe S, Wakayama M, Yokouchi Y, (2005) Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease. Pediatrics international 47: 305-310.
37. Davis-Dusenbery BN, Wu C, Hata A, (2011) Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation. Arterioscler Thromb Vasc Biol 31: 2370-2377.
38. Long X, Miano JM, (2011) Transforming growth factor-beta1 (TGF-beta1) utilizes distinct pathways for the transcriptional activation of microRNA 143/145 in human coronary artery smooth muscle cells. J Biol Chem 286: 30119-30129.
39. Elia L, Quintavalle M, Zhang J, Contu R, Cossu L, et al. (2009) The knockout of miR-143 and-145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ 16: 1590-1598.
40. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, et al. (2010) Circulating microRNAs in patients with coronary artery disease. Circ Res 107: 677-684.
41. Burgner D, Davila S, Breunis WB, Ng SB, Li Y, et al. (2009) A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genet 5: e1000319.
42. Fukazawa R, Sonobe T, Hamamoto K, Hamaoka K, Sakata K, et al. (2004) Possible synergic effect of angiotensin-I converting enzyme gene insertion/deletion polymorphism and angiotensin-II type-1 receptor 1166A/C gene polymorphism on ischemic heart disease in patients with Kawasaki disease. Pediatr Res 56: 597-601.
43. Shim YH, Kim HS, Sohn S, Hong YM, (2006) Insertion/deletion polymorphism of angiotensin converting enzyme gene in Kawasaki disease. J Korean Med Sci 21: 208-211.
44. Takeuchi K, Yamamoto K, Kataoka S, Kakihara T, Tanaka A, et al. (1997) High incidence of angiotensin I converting enzyme genotype II in Kawasaki disease patients with coronary aneurysm. Eur J Pediatr 156: 266-268.
45. Wu SF, Chang JS, Peng CT, Shi YR, Tsai FJ, (2004) Polymorphism of angiotensin-1 converting enzyme gene and Kawasaki disease. Pediatr Cardiol 25: 529-533.
46. Montecalvo A, Larregina AT, Shufesky WJ, Stolz DB, Sullivan ML, et al. (2012) Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 119: 756-766.
47. Taylor DD, Gercel-Taylor C, (2008) MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110: 13-21.
48. Creemers EE, Tijsen AJ, Pinto YM, (2012) Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res 110: 483-495.
49. da Costa Martins PA, Salic K, Gladka MM, Armand AS, Leptidis S, et al. (2010) MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat Cell Biol 12: 1220-1227.
50. Lin Z, Murtaza I, Wang K, Jiao J, Gao J, et al. (2009) miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy. Proc Natl Acad Sci U S A 106: 12103-12108.
51. Yonesaka S, Nakada T, Sunagawa Y, Tomimoto K, Naka S, et al. (1989) Endomyocardial biopsy in children with Kawasaki disease. Acta Paediatr Jpn 31: 706-711.
52. Vasudevan S, Tong Y, Steitz JA, (2007) Switching from repression to activation: microRNAs can up-regulate translation. Science 318: 1931-1934.
53. Zhang M, Jin M, Yu Y, Zhang S, Wu Y, et al. (2012) Associations of miRNA polymorphisms and female physiological characteristics with breast cancer risk in Chinese population. Eur J Cancer Care (Engl) 21: 274-280.
54. Lindsay ME, Dietz HC, (2011) Lessons on the pathogenesis of aneurysm from heritable conditions. Nature 473: 308-316.
55. Zhu H, Li Y, Qu S, Luo H, Zhou Y, et al. (2012) MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma. J Clin Immunol 32: 514-522.
56. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, et al. (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 108: 5003-5008.